Science, Policy & Pandemics: Episode 14 - Vaccines
In the 14th episode of our series on science, policy and pandemics, we're talking about vaccines and immunology. Throughout this episode, our host Rob Doubleday is joined by Dr Caroline Trotter, Dr Estee Torok, and Dr Flavio Toxvaerd. They explore our current understanding of the immunology and of vaccines under development; challenges involved in vaccine distribution, and insights we’ve gained about innovation and knowledge exchange throughout the vaccine development process.
CSaP's Science and Policy Podcast is a production of the Centre for Science and Policy at the University of Cambridge. This series on science, policy and pandemics is produced in partnership with Cambridge Infectious Diseases and the Cambridge Immunology Network.
Our guests this week:
Dr Caroline Trotter is an epidemiologist and a Principal Research Associate, Department of Veterinary Medicine at the University of Cambridge. She is also the Academic Director Cambridge Africa in the Department of Pathology, and is an Honorary Epidemiologist at Public Health England.
Dr Estee Torok is a Consultant in Infectious Diseases at Addenbrooke’s Hospital, Cambridge and a researcher at Cambridge's Department of Medicine. Her research focuses on translating microbial genomics into clinical practice. She is presently working with the NHS Trusts in Cambridgeshire as part of the COV002 vaccine trial which has been developed by the University of Oxford.
Dr Flavio Toxvaerd is a university lecturer at the University of Cambridge, where he specialises in microeconomic theory. He has recently been working on the covid-19 response, including through work on the global impact of coronavirus, and on the economics of how search and matching models can be useful for understanding economic and virological aspects of the coronavirus epidemic.
CSaP: The Science & Policy Podcast is hosted by CSaP Executive Director Dr Rob Doubleday, and is edited and produced by CSaP Communications Coordinator Kate McNeil. If you have feedback about this episode, or questions you would like us to address in a future week, please email email@example.com.